BC Extra | Jun 14, 2017
Financial News

GenMark raises $75M in upsized follow-on

Molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at $11.75 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, William Blair, Cowen and Raymond James....
BC Week In Review | May 3, 2010
Clinical News

ESensor Thrombophilia Risk Test regulatory update

FDA granted 510(k) clearance for Osmetech's eSensor Thrombophilia Risk Test to screen for 4 genetic markers associated with thrombosis, including Factor V Leiden, Factor II Prothrombin, MTHFR 677 and MTHFR 1298. The test was designed...
Items per page:
1 - 2 of 2